封面
市場調查報告書
商品編碼
1741408

止痛貼市場:按類型、按應用、按技術、按劑型、按配方、按患者年齡、按黏合特性、按作用持續時間、按藥物類別、按分銷管道、按地區

Pain Patch Market, By Type, By Application, By Technology, By Formulation, By Prescription, By Patient Age, By Adhesive Properties, By Duration of Action, By Drug Class, By Distribution Channel, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2025 年止痛貼市場價值估計為 58.3 億美元,預計到 2032 年將達到 82 億美元,2025 年至 2032 年的年複合成長率為 5%。

報告範圍 報告詳細資訊
基準年 2024 2025年的市場規模 58.3億美元
效能數據 從2020年到2024年 預測期 2025年至2032年
預測期:2025-2032年年複合成長率: 5.00% 2032年價值預測 82億美元

止痛貼,又稱經皮吸收貼片,是一種黏性貼劑,可直接透過皮膚釋放藥物,緩解局部疼痛。這類貼片使用方便,易於使用,並可在較長時間內控制藥物釋放。

市場動態:

疼痛貼片市場的成長主要源自於慢性疼痛疾病(如關節炎、下背痛和神經病變疼痛)的日益普及。這些疾病需要長期的疼痛管理方案,而疼痛貼片則提供了一種方便有效的解決方案。此外,人們越來越意識到口服止痛藥的潛在風險,例如成癮和胃腸道副作用,這促使人們更加關注像疼痛貼片這樣的非侵入性給藥系統。

然而,市場成長仍面臨許多阻礙因素。與傳統止痛藥相比,止痛貼價格昂貴,且部分地區對此類產品的報銷有限,這些因素可能會限制市場擴張。此外,止痛貼的核准監管要求嚴格,且使用止痛貼可能引發皮膚刺激和過敏反應,這些因素也對市場成長構成挑戰。

儘管面臨諸多挑戰,止痛貼市場仍蘊藏著許多成長機會。無線連接和感測器整合等先進技術在止痛貼中的應用日益廣泛,為創新和產品差異化鋪平了道路。此外,新興市場尚未開發的潛力以及對個人化疼痛管理解決方案日益成長的需求,為市場參與者擴大影響力、滿足多樣化消費群體的機會提供了良機。

本研究的主要特點

  • 本報告對全球止痛貼市場進行了詳細分析,並給出了預測期(2025-2032)的市場規模和年複合成長率(CAGR%),假設 2024 年為基準年。
  • 它還揭示了各個領域的潛在商機,並說明了該市場的引人注目的投資提案矩陣。
  • 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
  • 它根據公司亮點、產品系列、關鍵亮點、財務業績和策略等參數,對全球止痛貼市場中的主要企業進行了概述。
  • 本報告的見解可以幫助負責人和公司經營團隊就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
  • 全球止痛貼市場報告迎合了該行業的各個相關人員,例如投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
  • 相關人員將透過用於分析全球止痛貼市場的各種策略矩陣更輕鬆地做出決策。

目錄

第1章 調查目的與前提條件

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告描述
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章市場動態、法規與趨勢分析

  • 市場動態
    • 對有效緩解疼痛和非侵入性治療的需求不斷增加
    • 皮膚敏感和刺激
    • 個性化疼痛管理的出現
  • 影響分析
  • 主要亮點
  • 監管情景
  • 產品發布/核准
  • PEST分析
  • 波特分析
  • 併購場景

第4章 止痛貼市場-冠狀病毒(COVID-19)大流行的影響

  • COVID-19流行病學
  • 供需側分析
  • 經濟影響

5. 2020 年至 2032 年止痛貼市場(按類型)

  • 鴉片類藥物
  • 非鴉片類藥物

6. 2020 年至 2032 年止痛貼市場(按應用)

  • 慢性疼痛
  • 急性疼痛

7. 2020 年至 2032 年止痛貼市場(依技術分類)

  • 常規藥物輸送貼片
  • 先進的藥物傳輸貼片

8. 2020-2032 年止痛貼市場(以劑型分類)

  • 單一代理
  • 聯合治療

9. 2020 年至 2032 年止痛貼市場(依配方)

  • 處方
  • OTC

第 10 章。 2020 年至 2032 年依病患年齡分類的止痛貼市場

  • 成人
  • 孩子們

第 11 章 2020 年至 2032 年止痛貼市場(依黏合劑特性)

  • 低過敏性
  • 標準

第 12 章。 2020 年至 2032 年止痛貼市場(依作用持續時間分類)

  • 短效
  • 緩釋性

第 13 章。 2020 年至 2032 年止痛貼市場(依藥物類別分類)

  • 非類固醇抗發炎藥貼劑
  • 局部麻醉貼片
  • 其他

第 14 章。 2020 年至 2032 年按通路分類的止痛貼市場

  • 零售藥局
  • 醫院和診所

第 15 章。 2020 年至 2032 年按地區分類的止痛貼市場

  • 北美洲
      • 美國
      • 加拿大
  • 歐洲
      • 德國
      • 英國
      • 法國
      • 義大利
      • 西班牙
      • 俄羅斯
      • 其他歐洲國家
  • 亞太地區
      • 中國
      • 印度
      • 日本
      • 澳洲
      • 韓國
      • ASEAN
      • 其他亞太地區
  • 拉丁美洲
      • 巴西
      • 墨西哥
      • 阿根廷
      • 其他拉丁美洲
  • 中東
      • GCC
      • 以色列
      • 其他中東地區
  • 非洲
      • 南非
      • 中部非洲
      • 北非

第16章競爭格局

  • Hisamitsu Pharmaceutical Co., Inc.
  • Johnson & Johnson
  • Pfizer Inc.
  • Novartis AG
  • Mylan NV
  • Endo Pharmaceuticals
  • Teikoku Pharma USA, Inc.
  • Acorda Therapeutics
  • Ibsa Institut Biochimique SA
  • Alembic Pharmaceuticals
  • Noven Pharmaceuticals, Inc.
  • Teva Pharmaceuticals
  • Strativa Pharmaceuticals
  • Galen Limited
  • Napp Pharmaceuticals

第 17 章 章節

  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI6204

Pain Patch Market is estimated to be valued at USD 5.83 Bn in 2025 and is expected to reach USD 8.2 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 5.83 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 5.00% 2032 Value Projection: USD 8.2 Bn

Pain patches, also known as transdermal patches, are adhesive patches that deliver medication directly through the skin to provide localized pain relief. These patches are convenient, easy to use, and offer a controlled release of medication over an extended period.

Market Dynamics:

The pain patch market is primarily driven by the increasing prevalence of chronic pain conditions, such as arthritis, back pain, and neuropathic pain. These conditions require long-term pain management solutions, and pain patches offer a convenient and effective option. Moreover, the rising awareness about the potential risks associated with oral pain medications, such as addiction and gastrointestinal side effects, is shifting the focus towards non-invasive drug delivery systems like pain patches.

However, the market growth may be hindered by certain factors. The high cost of pain patches compared to traditional pain medications and the limited availability of reimbursement for these products in some regions may restrict market expansion. Additionally, the stringent regulatory requirements for the approval of pain patches and the risk of skin irritation or allergic reactions associated with patch usage pose challenges to market growth.

Despite these challenges, the pain patch market presents several opportunities for growth. The increasing adoption of advanced technologies, such as wireless connectivity and sensor integration in pain patches, opens up avenues for innovation and product differentiation. Furthermore, the untapped potential of emerging markets and the growing demand for personalized pain management solutions provide opportunities for market players to expand their presence and cater to a diverse consumer base.

Key features of the study:

  • This report provides in-depth analysis of the global pain patch market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global pain patch market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Hisamitsu Pharmaceutical Co., Inc., Johnson & Johnson, Pfizer Inc., Novartis AG, Mylan N.V., Endo Pharmaceuticals, Teikoku Pharma USA, Inc., Acorda Therapeutics, Ibsa Institut Biochimique SA, Alembic Pharmaceuticals, Noven Pharmaceuticals, Inc., Teva Pharmaceuticals, Strativa Pharmaceuticals, Galen Limited, and Napp Pharmaceuticals
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global pain patch market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pain patch market

Detailed Segmentation:

  • Global Pain Patch Market, By Type
    • Opioid Pain Patches
    • Non-Opioid Pain Patches
  • Global Pain Patch Market, By Application
    • Chronic Pain Patches
    • Acute Pain Patches
  • Global Pain Patch Market, By Technology
    • Traditional Drug Delivery Patches
    • Advanced Drug Delivery Patches
  • Global Pain Patch Market, By Formulation
    • Single Medication Patches
    • Combination Therapy Patches
  • Global Pain Patch Market, By Prescription
    • Prescription Pain Patches
    • Over-the-Counter (OTC) Pain Patches
  • Global Pain Patch Market, By Patient Age
    • Adult Pain Patches
    • Pediatric Pain Patches
  • Global Pain Patch Market, By Adhesive Properties
    • Hypoallergenic Patches
    • Standard Adhesive Patches
  • Global Pain Patch Market, By Duration of Action
    • Short-Acting Patches
    • Extended-Release Patches
  • Global Pain Patch Market, By Drug Class
    • NSAID Patches
    • Local Anesthetic Patches
    • Other Medication Patches
  • Global Pain Patch Market, By Distribution Channel
    • Retail Pharmacies
    • Hospitals and Clinics
  • Global Pain Patch Market, By Geography
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa
  • Company Profiles
    • Hisamitsu Pharmaceutical Co., Inc.
    • Johnson & Johnson
    • Pfizer Inc.
    • Novartis AG
    • Mylan N.V.
    • Endo Pharmaceuticals
    • Teikoku Pharma USA, Inc.
    • Acorda Therapeutics
    • Ibsa Institut Biochimique SA
    • Alembic Pharmaceuticals
    • Noven Pharmaceuticals, Inc.
    • Teva Pharmaceuticals
    • Strativa Pharmaceuticals
    • Galen Limited
    • Napp Pharmaceuticals

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet , By Type
    • Market Snippet , By Application
    • Market Snippet , By Technology
    • Market Snippet , By Formulation
    • Market Snippet , By Prescription
    • Market Snippet , By Patient Age
    • Market Snippet , By Adhesive Properties
    • Market Snippet , By Duration of Action
    • Market Snippet , By Drug Class
    • Market Snippet , By Distribution Channel
    • Market Snippet , By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Growing demand for effective pain relief and non-invasive treatment
    • Skin Sensitivity and Irritation
    • Emergence of Personalized Pain Management
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Pain Patch Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Pain Patch Market, By Type, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Opioid Pain Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Non-Opioid Pain Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

6. Pain Patch Market, By Application, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Chronic Pain Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Acute Pain Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

7. Pain Patch Market, By Technology, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Traditional Drug Delivery Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Advanced Drug Delivery Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

8. Pain Patch Market, By Formulation, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Single Medication Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Combination Therapy Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

9. Pain Patch Market, By Prescription, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Prescription Pain Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Over-the-Counter (OTC) Pain Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

10. Pain Patch Market, By Patient Age, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Adult Pain Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Pediatric Pain Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

11. Pain Patch Market, By Adhesive Properties, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hypoallergenic Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Standard Adhesive Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

12. Pain Patch Market, By Duration of Action, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Short-Acting Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Extended-Release Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

13. Pain Patch Market, By Drug Class, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • NSAID Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Local Anesthetic Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Other Medication Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

14. Pain Patch Market, By Distribution Channel, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Hospitals and Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

15. Pain Patch Market, By Region, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Country, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Country 2021 -2032
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Prescription, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Age, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Adhesive Properties, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Duration of Action, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Prescription, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Age, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Adhesive Properties, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Duration of Action, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Prescription, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Age, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Adhesive Properties, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Duration of Action, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Prescription, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Age, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Adhesive Properties, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Duration of Action, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Prescription, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Age, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Adhesive Properties, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Duration of Action, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Prescription, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Age, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Adhesive Properties, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Duration of Action, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • South Africa
      • Central Africa
      • North Africa

16. Competitive Landscape

  • Hisamitsu Pharmaceutical Co., Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Johnson & Johnson
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Pfizer Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Novartis AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Mylan N.V.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Endo Pharmaceuticals
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Teikoku Pharma USA, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Acorda Therapeutics
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Ibsa Institut Biochimique SA
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Alembic Pharmaceuticals
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Noven Pharmaceuticals, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Teva Pharmaceuticals
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Strativa Pharmaceuticals
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Galen Limited
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Napp Pharmaceuticals
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

17. Section

  • Research Methodology
  • About us